Serapha Bio

Private

United StatesHealthcare & Life Scienceshttps://www.seraphabio.com/

Last Round

Series A

Jun 23, 2026

Est. Valuation

$303.7M

Company Overview

Serapha Bio is a biotechnology company developing an investigational in vivo base editing therapy for Alpha-1 Antitrypsin Deficiency (AATD).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

base editinggene editingin vivo therapyAlpha-1 Antitrypsin DeficiencyAATDgenetic disorderprecision medicinebiotechclinical-stage biotechtherapeutic assetgenetic medicinegenomic medicinedrug developmentCRISPR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Serapha Bio Comparables

Compare Serapha Bio with similar companies based on industry and business-model similarity.

Serapha Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
AIRNA	89%
Beam Therapeutics	88%
Frequency Therapeutics	87%

View all Comparables

Serapha Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jun 23, 2026

View all Funding Rounds

Serapha Bio Investors

Notable investors and investment history

Serapha Bio investors
Investor	Rounds
Janus Henderson Group	Series A
Balyasny Asset Management L.P.	Series A
RA Capital Management	Series A
LifeSci Venture Partners	Series A
Eventide Funds	Series A
Logos Capital	Series A
Casdin Capital	Series A

View all Investors

Serapha Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Serapha Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Serapha Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States

Year Founded2026

Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?